Jing Lü

This study introduces HCQ-functionalized LNPs that reduce inflammation while maintaining mRNA delivery efficiency, showing promise for repeated dosing applications.

This paper identifies CTHRC1 as a therapeutic target and serum biomarker for aortic dissection, showing it regulates VSMC phenotype and aortic integrity via the ERK1/2 pathway.

This paper develops a novel peripherally acting alpha2A-adrenergic receptor antagonist, CDS479-2, which improves glucose control in diabetic mice without central side effects.